Table 1.

Susceptibility results as reported by the BD-Phoenix instrument (BD Diagnostics, Inc., Sparks, MD) using the NMIC/ID 132 panel on the organisms identified

AntimicrobialaMIC (μg/ml)b
Klebsiella pneumoniaeSalmonella Senftenberg
Amikacin>32>32
Ampicillin>16>16
Ampicillin-sulbactam>16/8>16/8
Aztreonam>16>16
Cefazolin>16>16
Cefepime>16>16
Cefoxitin>16>16
Ceftriaxone>32>32
Ciprofloxacin>2>2
Colistin0.12*ND
Ertapenem>8>8
Gentamicin>8>8
Imipenem>8>8
Meropenem>82
Moxifloxacin>4>4
Piperacillin-tazobactam>64/4>64/4
Tetracycline84
Ticarcillin-clavulanic acid>64/8>64/2
Tigecycline>82
Tobramycin>8>8
TMP-SMX>2/38<0.5/9.5
  • a TMP-SMX, trimethoprim-sulfamethoxazole.

  • b MICs in bold are not reported to clinicians. *, colistin MIC determined using the broth macrodilution method.